CHELMSFORD, Mass., Nov. 15, 2018 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS), a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, announced today that it has closed its previously announced acquisition of GENEWIZ Group.
NASHVILLE, TN and SOUTH PLAINFIELD, NJ – October 16, 2018 - Nashville Biosciences, a robust and highly-skilled bioinformatics and genomics company, and GENEWIZ (ASHG, booth #1237), a leading global genomics service provider, today announced at the American Society of Human Genetics (ASHG) Conference a new collaboration that will streamline researchers’ access to biological insights by combining Nashville Biosciences’ BioVU® biobank with GENEWIZ’s next generation sequencing.
Leading global genomics service provider, GENEWIZ, announced at the American Society of Human Genetics (ASHG) Conference today that it has expanded its CLIA-compliant service offering into next generation sequencing (NGS). ASHG runs through October 20, 2018 at the San Diego Convention Center.
SOUTH PLAINFIELD, NJ, September 26, 2018 – GENEWIZ announced today that it has entered into a definitive agreement to be acquired by Brooks Automation, Inc. GENEWIZ is a leading global genomics service provider with laboratory operations in the United States, the United Kingdom, Germany, China, and Japan.
Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leading provider of high-quality sequencing systems for genomes, transcriptomes and epigenomes, and GENEWIZ, a leading global genomics service provider, today announced that Professor Dr. Arne Nolte of the Institute for Biology and Environmental Sciences at the University of Oldenburg, Germany and Assistant Professor Dr. Fritz Sedlazeck from the Human Genome Sequencing Center at Baylor College of Medicine in Houston, have been awarded the 2018 Plant and Animal SMRT® Grant. The grant will provide Nolte and Sedlazeck access to the PacBio® Sequel® System at GENEWIZ, as well as the materials needed and bioinformatics support to conduct comparative genomics on the newly discovered European cavefish.
South Plainfield, NJ – April 30, 2018 – Leading global genomics service provider, GENEWIZ, celebrated the grand opening of its newly expanded global headquarters on April 25 with a ribbon-cutting ceremony at its state-of-the-art office complex in South Plainfield, NJ.
Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor Stephen Scherer, Ph.D., Co-founder and Director of the Centre for Applied Genomics at University of Toronto’s Hospital for Sick Children and Director of the University of Toronto McLaughlin Centre, is the winner of the 2017 Structural Variant SMRT Grant.
South Plainfield, N.J. — November 2017 — Leading global genomics service provider, GENEWIZ, was recently recognized by the New Jersey Business & Industry Association’s 2017 Awards for Excellence with the Outstanding Employer Award. This comes on the heels of being named to NJBIZ’s list of the 50 Fastest Growing Companies in New Jersey for the fifth year in the row.
Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, and GENEWIZ, the leading global genomics service provider, announce that Andrew Ludlow, Ph.D. from the University of Michigan, is the winner of the AACR SMRT® Grant. With this SMRT Grant, Dr. Ludlow will receive Iso-Seq® analysis on the PacBio® Sequel® System at the GENEWIZ laboratory to further his investigation to understand the splicing of transcripts regulated by NOVA1 in lung cancer cells.
South Plainfield, N.J. and Orlando, Fla. (ASHG17, Booth #323) — October 17, 2017 — Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting. ASHG is the largest gathering of human genetics professionals in the world and takes place this October 17-21, 2017 in Orlando.
South Plainfield, N.J. and Washington, D.C. (AACR17, Booth #3431). — Mar 28, 2017 — Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level..
South Plainfield, NJ – November 15, 2016 – Leading global genomics service provider, GENEWIZ, was recently named to the Inc. 5000 list of fastest-growing private companies in the United States for the third consecutive year.
MOUNTAIN VIEW, Calif. — Oct 24, 2016 — Based on its recent analysis of the life science research services market, Frost & Sullivan recognizes GENEWIZ with the 2016 North America Frost & Sullivan Company of the Year Award. GENEWIZ's strategic decisions to reinvest in itself and expand its infrastructure, geographies, and customer channels have enabled it to emerge as a leader in this intensely competitive market. Its recent acquisition of Beckman Coulter Genomics (BCG) and implementation of multiple new genomics platforms demonstrate its commitment to growth and delivering cutting-edge research services using various genomics technologies and techniques.
SOUTH PLAINFIELD, NJ and SAN DIEGO – Oct. 5, 2016 – GENEWIZ, a leading global genomics services provider, today announced it will implement multiple Edico Genome DRAGEN™ Bio-IT processors to accelerate the analysis of massive volumes of genomic data generated by its high-throughput sequencing platforms. GENEWIZ’s already quick turnaround times are expected to be reduced by days for large next-generation sequencing (NGS) data sets, without sacrificing data quality or integrity.
South Plainfield, NJ and Boston – September 27, 2016 - GENEWIZ, a leading global genomics services provider, opened a new flagship laboratory in Cambridge, MA on Wednesday September 21st 2016. The addition of Oligo Synthesis and Plasmid Preparation services to the new Cambridge laboratory enhances the local Boston Sanger DNA sequencing services, providing increased speed and convenience to the customer.
South Plainfield, NJ – April 15, 2016 –GENEWIZ, a leading global genomics services provider, announced today it has acquired multiple high-throughput sequencing (also known as Next Generation Sequencing (NGS)) platforms including the Illumina HiSeq X Ten, PacBio Sequel, and 10x Genomics Chromium. The addition of these cutting-edge systems strengthens the scope of the NGS services GENEWIZ offers the scientific community worldwide.
GENEWIZ, a leading global genomics services provider, recently collaborated with the National Key Laboratory of Biotherapy of Sichuan University in China, to synthesize the key genes of the Zika virus as part of expedited research and development into drugs and vaccines to combat the infectious disease.
GENEWIZ, a leading global genomics services provider, announced today that it had received an investment to support its growth activities. The terms of the investment were not disclosed. The financing was led by OrbiMed, a healthcare-dedicated investment firm, and participated in by Ampersand Capital Partners and Prime Value Capital Management (PVCM).
Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS).
Leading global genomics service provider, GENEWIZ, has been named to the Inc. 5000 for the second year in a row. The 34th annual Inc. 5000 is Inc. magazine’s exclusive ranking of the fastest-growing private companies in the United States.
Leading global genomics service provider, GENEWIZ, will discuss its antibody workflow solutions at the Seventh Annual PEGS Europe Protein & Antibody Engineering Summit, November 2-6 in Lisbon, Portugal.
Leading global genomics service provider, GENEWIZ, announced a partnership with Hy Laboratories Ltd. (hylabs), Israel’s premier provider of microbiology and molecular and cell biology products and services...
GENEWIZ, Inc., the #1 provider of Sanger DNA sequencing services in the United States, announced a strategic partnership to provide integrated solutions to streamline DNA-based services from ordering to data analysis...
GENEWIZ, Inc., leader in global DNA services, today announced that Dr. Steve Sun, CEO and Dr. Amy Liao, COO, co-founders of GENEWIZ, Inc. received the Ernst & Young Entrepreneur Of The Year 2010 Award in the Service category for New Jersey...
GENEWIZ, Inc. the largest provider of research-based Sanger DNA sequencing in the United States, has introduced an updated logo that emphasizes the company's long-standing commitment to excellence in both science and customer support...
In honor of the 40th Earth Day, GENEWIZ, Inc. announced its “GENEWIZ Goes Green” program, a series of initiatives to reduce environmental impact and encourage employees to undertake additional, ongoing environmentally friendly projects. As a reminder to celebrate Earth Day, GENEWIZ’s website will change from blue to “green” on April 22, for one week...
GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services. Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning...